戻る Agenda
LS20 Open Innovation in Drug Development in Japan: Preparations in Normal Times, Challenges, and Practices
Session Chair(s)
Makoto Nagaoka, PhD
Senior Director, Head of Regulatory Affairs Japan,Global Regulatory Strategy, Co, Fortrea Japan K.K., Japan
Speaker(s)
Kotone Matsuyama, RPh
Center for Clinical Research and Development, National Center for Child Health and Development, Japan
Keiichi Fukuda, MD, PhD
Professor, Department of Regenerative Medicine and Advanced Cardiac Therapeutics, Graduate School of Medicine, Keio University, Japan
Noriatsu Kono, MPharm
Organizational management, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Liu Lei
Innovation Partnerships & i2.JP Director , AstraZeneca K.K., Japan